Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2021 Filed Dec 17, 2021 15:54 UTC |
Cox HeatherChief Dig Health & Analyt Off.
|
Exercise / conversionHumana Common | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013075 · form4.xml · nonDerivative · entry 1 Cox Heather · CIK 0001734706 · Chief Dig Health & Analyt Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:45 UTC |
Deshpande SamirChief Information Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013073 · form4.xml · derivative · entry 13 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 701 Underlying: Humana Common · 350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:45 UTC |
Deshpande SamirChief Information Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013073 · form4.xml · derivative · entry 12 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380 Underlying: Humana Common · 380 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:45 UTC |
Deshpande SamirChief Information Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013073 · form4.xml · derivative · entry 11 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/25/19, 33% of the award is vesting on 12/15/19, 12/15/20 and 12/15/21. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/25/19, 33% of the award is vesting on 12/15/19, 12/15/20 and 12/15/21. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:45 UTC |
Deshpande SamirChief Information Officer
|
Tax withholdingHumana Common | 158 | $459.85 | $72,656.30 |
DisclosureSEC source: 0001062993-21-013073 · form4.xml · nonDerivative · entry 6 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,964 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:45 UTC |
Deshpande SamirChief Information Officer
|
Exercise / conversionHumana Common | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013073 · form4.xml · nonDerivative · entry 5 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:45 UTC |
Deshpande SamirChief Information Officer
|
Tax withholdingHumana Common | 172 | $459.85 | $79,094.20 |
DisclosureSEC source: 0001062993-21-013073 · form4.xml · nonDerivative · entry 4 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,772 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:45 UTC |
Deshpande SamirChief Information Officer
|
Exercise / conversionHumana Common | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013073 · form4.xml · nonDerivative · entry 3 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:45 UTC |
Deshpande SamirChief Information Officer
|
Tax withholdingHumana Common | 184 | $459.85 | $84,612.40 |
DisclosureSEC source: 0001062993-21-013073 · form4.xml · nonDerivative · entry 2 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,564 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:45 UTC |
Deshpande SamirChief Information Officer
|
Exercise / conversionHumana Common | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013073 · form4.xml · nonDerivative · entry 1 Deshpande Samir · CIK 0001712481 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,748 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Exercise / conversionRestricted Stock Units · Derivative | 389 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · derivative · entry 14 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 779 Underlying: Humana Common · 389 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F10 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. F10 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Exercise / conversionRestricted Stock Units · Derivative | 428 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · derivative · entry 13 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428 Underlying: Humana Common · 428 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Exercise / conversionRestricted Stock Units · Derivative | 542 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · derivative · entry 12 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 542 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 2/25/19, 33% of the award is vesting on 12/15/19, 12/15/20 and 12/15/21. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 2/25/19, 33% of the award is vesting on 12/15/19, 12/15/20 and 12/15/21. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Tax withholdingHumana Common | 179 | $459.85 | $82,313.15 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · nonDerivative · entry 6 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,547 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Exercise / conversionHumana Common | 389 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · nonDerivative · entry 5 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Tax withholdingHumana Common | 197 | $459.85 | $90,590.45 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · nonDerivative · entry 4 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,337 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Exercise / conversionHumana Common | 428 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · nonDerivative · entry 3 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Tax withholdingHumana Common | 249 | $459.85 | $114,502.65 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · nonDerivative · entry 2 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,106 Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 15:43 UTC |
Fleming William KevinSeg Pres, Pharmacy Sol & CCAO
|
Exercise / conversionHumana Common | 542 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013071 · form4.xml · nonDerivative · entry 1 Fleming William Kevin · CIK 0001699801 · Seg Pres, Pharmacy Sol & CCAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2021 Filed Dec 14, 2021 15:26 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 811 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-012833 · form4.xml · derivative · entry 7 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 811 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 12/11/2018, 33% of the award is vesting on 12/11/2019, 12/11/2020 and 12/11/2021. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 12/11/2018, 33% of the award is vesting on 12/11/2019, 12/11/2020 and 12/11/2021. Read SEC document |
| December 11, 2021 Filed Dec 14, 2021 15:26 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
Tax withholdingHumana Common | 285 | $455.64 | $129,857.40 |
DisclosureSEC source: 0001062993-21-012833 · form4.xml · nonDerivative · entry 2 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,282 Read SEC document |
| December 11, 2021 Filed Dec 14, 2021 15:26 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
Exercise / conversionHumana Common | 811 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-012833 · form4.xml · nonDerivative · entry 1 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 15:21 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionOptions · Derivative | 26,939 | $0.00 Strike: $307.97 | $0.00 |
DisclosureSEC source: 0001062993-21-010469 · form4.xml · derivative · entry 6 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,470 Underlying: Humana Common · 40,409 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three annual increments. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three annual increments. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 15:21 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionOptions · Derivative | 14,346 | $0.00 Strike: $268.47 | $0.00 |
DisclosureSEC source: 0001062993-21-010469 · form4.xml · derivative · entry 5 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372 Underlying: Humana Common · 14,718 shares Expires 2025-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three annual increments. F1 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three annual increments. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 15:21 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
SaleHumana Common | 8,721 | $457.40 | $3,989,013.31 |
DisclosureSEC source: 0001062993-21-010469 · form4.xml · nonDerivative · entry 4 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,294 F10 · price: Reported price is weighted average sales price. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 15:21 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
SaleHumana Common | 41,285 | $454.13 | $18,748,752.92 |
DisclosureSEC source: 0001062993-21-010469 · form4.xml · nonDerivative · entry 3 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,015 F10 · price: Reported price is weighted average sales price. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 15:21 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionHumana Common | 26,939 | $307.97 | $8,296,269.14 |
DisclosureSEC source: 0001062993-21-010469 · form4.xml · nonDerivative · entry 2 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 15:21 UTC |
BROUSSARD BRUCE DDirector · President & CEO
|
Exercise / conversionHumana Common | 14,346 | $268.47 | $3,851,470.62 |
DisclosureSEC source: 0001062993-21-010469 · form4.xml · nonDerivative · entry 1 BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 14:11 UTC |
KATZ KARENDirector
|
GrantRestricted Stock Units · Derivative | 72 | $394.00 | $28,367.64 |
DisclosureSEC source: 0000049071-21-000128 · edgar.xml · derivative · entry 3 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 513 Underlying: Humana Common · 72 shares Expires not disclosed F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 13:38 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 209 | $394.00 | $82,344.96 |
DisclosureSEC source: 0000049071-21-000127 · edgar.xml · derivative · entry 4 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,071 Underlying: Humana Common · 209 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 13:37 UTC |
McDonald William J.Director
|
GrantRestricted Stock Units · Derivative | 72 | $394.00 | $28,367.64 |
DisclosureSEC source: 0000049071-21-000126 · edgar.xml · derivative · entry 3 McDonald William J. · CIK 0001415604 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,677 Underlying: Humana Common · 72 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 13:07 UTC |
JONES DAVID A JR/KYDirector
|
SaleHumana Common | 4,800 | $401.00 | $1,924,800.00 |
DisclosureSEC source: 0000049071-21-000125 · edgar.xml · nonDerivative · entry 3 JONES DAVID A JR/KY · CIK 0001025393 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 67,925 F6 · shares: Shares contributed by the David Jones Jr. Revocable Trust to an exchange fund in return for shares of the exchange fund. The Humana Inc. common stock was valued at $401.00 per share, using close of business price on the day prior to the exchange date, for purposes of determining the number of shares of the exchange fund issued to the Revocable Trust. F4 · ownership.nature: Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock. Includes 453 shares that vested on 12/31/20 and transferred to trust on 1/4/21. Read SEC document |
| September 04, 2021 Filed Sep 8, 2021 13:16 UTC |
Bono Raquel C.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 397 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-21-000123 · edgar.xml · derivative · entry 2 Bono Raquel C. · CIK 0001823759 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 397 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_date: Initial award of $165,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 9/4/2021 and forfeited in its entirety if service is less than one year. F2 · derivative.expiration_date: Initial award of $165,000 worth of restricted stock units pursuant to the annual Director's Fee Program. 100% of the award will vest on 9/4/2021 and forfeited in its entirety if service is less than one year. Read SEC document |
| September 04, 2021 Filed Sep 8, 2021 13:16 UTC |
Bono Raquel C.Director
|
Exercise / conversionHumana Common | 397 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-21-000123 · edgar.xml · nonDerivative · entry 1 Bono Raquel C. · CIK 0001823759 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 12:22 UTC |
Cox HeatherChief Dig Health & Analyt Off.
|
Exercise / conversionRestricted Stock Units · Derivative | 752 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-21-000118 · edgar.xml · derivative · entry 8 Cox Heather · CIK 0001734706 · Chief Dig Health & Analyt Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 752 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 9/1/2018, 33% of the award is vesting on 9/1/2019, 9/1/2020 and 9/1/2021. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 9/1/2018, 33% of the award is vesting on 9/1/2019, 9/1/2020 and 9/1/2021. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 12:22 UTC |
Cox HeatherChief Dig Health & Analyt Off.
|
Tax withholdingHumana Common | 184 | $403.05 | $74,161.20 |
DisclosureSEC source: 0000049071-21-000118 · edgar.xml · nonDerivative · entry 2 Cox Heather · CIK 0001734706 · Chief Dig Health & Analyt Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,605 Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 12:22 UTC |
Cox HeatherChief Dig Health & Analyt Off.
|
Exercise / conversionHumana Common | 752 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-21-000118 · edgar.xml · nonDerivative · entry 1 Cox Heather · CIK 0001734706 · Chief Dig Health & Analyt Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 12:24 UTC |
Schick Susan D.Seg Pres. Grp. & Military Bus.
|
GrantRestricted Stock Units · Derivative | 434 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-21-000119 · edgar.xml · derivative · entry 3 Schick Susan D. · CIK 0001881150 · Seg Pres. Grp. & Military Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434 Underlying: Humana Common · 434 shares Expires not disclosed F2 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_date: Restricted stock units granted to reporting person on 9/1/2021, 33% of the award is vesting on 9/1/22, 9/1/23, and 9/1/24. F3 · derivative.expiration_date: Restricted stock units granted to reporting person on 9/1/2021, 33% of the award is vesting on 9/1/22, 9/1/23, and 9/1/24. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 12:24 UTC |
Schick Susan D.Seg Pres. Grp. & Military Bus.
|
GrantOptions · Derivative | 1,765 | $0.00 Strike: $403.05 | $0.00 |
DisclosureSEC source: 0000049071-21-000119 · edgar.xml · derivative · entry 2 Schick Susan D. · CIK 0001881150 · Seg Pres. Grp. & Military Bus. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,765 Underlying: Humana Common · 1,765 shares Expires 2028-09-01 F1 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 9/1/2021, vesting in three annual increments from 9/1/22 to 9/1/24. F1 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 9/1/2021, vesting in three annual increments from 9/1/22 to 9/1/24. Read SEC document |
| August 01, 2021 Filed Aug 3, 2021 19:32 UTC |
Diamond Susan MChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 933 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-21-000113 · edgar.xml · derivative · entry 11 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933 Underlying: Humana Common · 933 shares Expires not disclosed F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F12 · derivative.exercise_date: Restricted stock units granted to reporting person on 08/1/2021, 33% of the award is vesting on 8/1/22, 8/1/23, and 8/1/24. F12 · derivative.expiration_date: Restricted stock units granted to reporting person on 08/1/2021, 33% of the award is vesting on 8/1/22, 8/1/23, and 8/1/24. Read SEC document |
| August 01, 2021 Filed Aug 3, 2021 19:32 UTC |
Diamond Susan MChief Financial Officer
|
GrantOptions · Derivative | 3,793 | $0.00 Strike: $428.68 | $0.00 |
DisclosureSEC source: 0000049071-21-000113 · edgar.xml · derivative · entry 5 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,793 Underlying: Humana Common · 3,793 shares Expires 2028-08-01 F4 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 8/1/2021, vesting in three annual increments from 8/1/22 to 8/1/24. F4 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 8/1/2021, vesting in three annual increments from 8/1/22 to 8/1/24. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 16:03 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 291 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-21-000106 · edgar.xml · derivative · entry 8 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291 Underlying: Humana Common · 291 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 07/01/19, 33% of the award is vesting on 07/01/20, 07/01/21, and 07/01/22. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 07/01/19, 33% of the award is vesting on 07/01/20, 07/01/21, and 07/01/22. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 16:03 UTC |
Diamond Susan MChief Financial Officer
|
Tax withholdingHumana Common | 92 | $445.00 | $40,940.00 |
DisclosureSEC source: 0000049071-21-000106 · edgar.xml · nonDerivative · entry 2 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,385 Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 16:03 UTC |
Diamond Susan MChief Financial Officer
|
Exercise / conversionHumana Common | 291 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-21-000106 · edgar.xml · nonDerivative · entry 1 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 15:30 UTC |
KATZ KARENDirector
|
GrantRestricted Stock Units · Derivative | 66 | $442.72 | $29,219.19 |
DisclosureSEC source: 0000049071-21-000105 · edgar.xml · derivative · entry 3 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 441 Underlying: Humana Common · 66 shares Expires not disclosed F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 15:20 UTC |
McDonald William J.Director
|
GrantRestricted Stock Units · Derivative | 66 | $442.72 | $29,219.19 |
DisclosureSEC source: 0000049071-21-000104 · edgar.xml · derivative · entry 3 McDonald William J. · CIK 0001415604 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,605 Underlying: Humana Common · 66 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 15:18 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 194 | $442.72 | $85,886.71 |
DisclosureSEC source: 0000049071-21-000103 · edgar.xml · derivative · entry 4 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,862 Underlying: Humana Common · 194 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| May 04, 2021 Filed May 6, 2021 15:25 UTC |
Fleming William KevinSeg Pres, Clin & Phm Solutions
|
Exercise / conversionOptions · Derivative | 1,391 | $0.00 Strike: $271.14 | $0.00 |
DisclosureSEC source: 0000049071-21-000090 · edgar.xml · derivative · entry 9 Fleming William Kevin · CIK 0001699801 · Seg Pres, Clin & Phm Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 1,391 shares Expires 2025-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 03/1/2018, vesting in three increments from 2/19/19 to 2/19/21. F3 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 03/1/2018, vesting in three increments from 2/19/19 to 2/19/21. Read SEC document |
| May 04, 2021 Filed May 6, 2021 15:25 UTC |
Fleming William KevinSeg Pres, Clin & Phm Solutions
|
Exercise / conversionOptions · Derivative | 6,623 | $0.00 Strike: $268.47 | $0.00 |
DisclosureSEC source: 0000049071-21-000090 · edgar.xml · derivative · entry 8 Fleming William Kevin · CIK 0001699801 · Seg Pres, Clin & Phm Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 6,623 shares Expires 2025-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three increments from 2/19/19 to 2/19/21. F2 · derivative.exercise_date: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three increments from 2/19/19 to 2/19/21. Read SEC document |
| May 04, 2021 Filed May 6, 2021 15:25 UTC |
Fleming William KevinSeg Pres, Clin & Phm Solutions
|
SaleHumana Common | 1,257 | $459.74 | $577,892.68 |
DisclosureSEC source: 0000049071-21-000090 · edgar.xml · nonDerivative · entry 6 Fleming William Kevin · CIK 0001699801 · Seg Pres, Clin & Phm Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,862 F14 · price: Price reported is weighed avg sales price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.